CurrentEndo
Get Weekly

Topic · page 31 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 1,201–1,240 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetologia

    Long-term effects of dietary protein and carbohydrate quality on prediabetes remission: results from the PREVIEW randomised multinational diabetes prevention trial

    Secondary analysis

  2. Diabetes Obes Metab

    Low serum 1,5‐anhydroglucitol is associated with increased risk of all‐cause and cardiovascular mortality in type 2 diabetes: A real‐world cohort study

    Cohort study

  3. Diabetes Obes Metab

    Comparative healthcare resource utilization and costs of empagliflozin and GLP ‐1 receptor agonists in type 2 diabetes

    Cohort study

  4. Endocr Pract

    Insulin Discontinuation in Youth With New-Onset Type 2 Diabetes Presenting With and Without Diabetic Ketoacidosis

    Cohort study

  5. Diabetes Metab

    Management of patients with type 2 diabetes and MASLD: An overview and joint statement

    Guideline or statement

  6. BMJ Open Diabetes Res Care

    Long-term comparative effectiveness of once-weekly semaglutide versus alternative treatments in a real-world US adult population with type 2 diabetes: a randomized pragmatic clinical trial

    Randomized controlled trial

  7. BMJ Open Diabetes Res Care

    Change in urine albumin-to-creatinine ratio and clinical outcomes in patients with chronic kidney disease and type 2 diabetes

    Cohort study

  8. Cardiovasc Diabetol

    Epicardial adipose tissue volume and arterial stiffness in people living with diabetes: the METAB-CV-PWV study

    Cohort study

  9. BMJ

    Sodium-glucose cotransporter-2 inhibitors and risk of autoimmune rheumatic diseases: population based cohort study

    Cohort study

  10. Diabetes Care

    Updating a Clinical Prediction Model for Identifying Monogenic Diabetes to Include Both Clinical Features and Biomarkers

    Diagnostic or prognostic study

  11. Diabetes Obes Metab

    Triple oral therapy with metformin, DPP ‐4 inhibitor, and SGLT2 inhibitor for adults with type 2 diabetes: Consensus recommendations of a Chinese expert panel (version 2025)

    Guideline or statement

  12. Diabetes Obes Metab

    Efficacy and safety of iGlarLixi versus IDegAsp by baseline β‐cell function in Chinese people with type 2 diabetes: Exploratory analyses of the Soli‐D study

    Secondary analysis

  13. Cardiovasc Diabetol

    Genetic variation in the glucagon-like peptide-1 receptor protein encoding region is associated with higher heart rate variability, but not with neurodegeneration of the brain, retina, and peripheral nerves: The Maastricht study

    Cohort study

  14. Diabetes Res Clin Pract

    A real-world study assessing the efficacy and safety of switching from basal bolus insulin therapy to once daily iGlarLixi in people with type 2 diabetes mellitus: soli de-escalation

    Cohort study

  15. Diabetes Res Clin Pract

    Adjunctive pancreatin therapy enhances glycemic and metabolic outcomes in type 2 diabetes mellitus: the modifying role of exocrine pancreatic function

    Cohort study

  16. Osteoporos Int

    Age at diabetes diagnosis and fracture risk in women: a cohort study from the Australian Longitudinal Study on Women’s Health

    Cohort study

  17. Lancet Diabetes Endocrinol

    Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysis

    Meta-analysis

  18. Diabetologia

    Daily life stress is linked to increased glucose levels in individuals with insulin resistance: a real-world assessment

    Cohort study

  19. Diabetes Res Clin Pract

    Awareness of diabetes stigma and advocacy among future physicians: insights from the first real-world survey among medical trainees in Japan

    Cross-sectional study

  20. Diabetes Obes Metab

    Partial non‐adherence to antidiabetic therapy undermines diabetes management and correlates with treatment complexity: A cross‐sectional study using blood plasma analysis

    Cross-sectional study

  21. Diabetes Obes Metab

    Glucagon‐like peptide‐1 receptor agonist and respiratory complications after endoscopy: A Japanese nationwide cohort study

    Cohort study

  22. Cardiovasc Diabetol

    Deep learning-based coronary calcium score derived from non-gated chest CT and major adverse cardiovascular events in patients with type 2 diabetes mellitus

    Cohort study

  23. Cardiovasc Diabetol

    Plasma ALKAL2 levels are associated with coronary atherosclerosis in patients with type 2 diabetes mellitus

    Case-control study

  24. Diabetologia

    DNA methylation of genes involved in lipid metabolism drives adiponectin levels and metabolic disease

    Meta-analysis

  25. J Clin Endocrinol Metab

    Effect of Weight Change on Type 2 Diabetes Risk: A Prospective Study in a Japanese Population

    Cohort study

  26. Diabetes Obes Metab

    Evaluating global epidemiology of type 2 diabetes mellitus among the working‐age population: A 60‐year study by interpretable machine learning framework

    Research article

  27. Diabetes Care

    Pilot Pragmatic Trial of a Community Paramedic Diabetes Self-Management Education Program for Adults With Diabetes

    Research article

  28. J Clin Endocrinol Metab

    Antigen-Presenting Cell Isolevuglandins Link Salt Sensitivity of Blood Pressure to Insulin Resistance

    Mechanistic study

  29. J Clin Endocrinol Metab

    Metformin Blunts Vascular Insulin Sensitivity After Exercise Training in Adults at Risk for Metabolic Syndrome

    Randomized controlled trial

  30. Diabetes Obes Metab

    Relative efficacy of GLP ‐1 and GLP ‐1/ GIP receptor agonists in the prevention of alcohol‐use disorders using a target trial emulation approach

    Cohort study

  31. Diabetes Obes Metab

    Reevaluating the causal link between liver fat and hyperglycaemia

    Meta-analysis

  32. Cardiovasc Diabetol

    Real-world cardiovascular effectiveness of sustained glucagon-like peptide 1 GLP-1 receptor agonist usage in type 2 diabetes

    Cohort study

  33. Diabet Med

    Beyond compliance: Lived experiences of type 2 diabetes self‐management in Wales

    Research article

  34. Diabetes Obes Metab

    Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes

    Meta-analysis

  35. BMJ Open Diabetes Res Care

    Investigating the association between incretin-based therapies and thyroid cancer incidence among US Medicare beneficiaries with diabetes

    Cohort study

  36. Diabetes Res Clin Pract

    Dietary glycocalyx mimetic reduces vascular risk in Type 2 diabetes: evidence from urinary peptidomic classifiers in a South–Asian Surinamese Cohort

    Randomized controlled trial

  37. Cardiovasc Diabetol

    Development and evaluation of a machine learning prediction model for short-term mortality in patients with diabetes or hyperglycemia at emergency department admission

    Cohort study

  38. Diabetes Obes Metab

    Association between accelerometer‐measured physical activity, genetic risk, and incident type 2 diabetes: A prospective cohort study

    Cohort study

  39. Diabetologia

    Prevalence of youth type 2 diabetes in global Indigenous populations: a systematic review

    Meta-analysis

  40. Diabetes Care

    Glycemic Level Modifies the Relationship Between Maternal Gestational Weight Gain and Neonatal Birth Weight in Type 2 Diabetes–Complicated Pregnancies

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 1,201–1,240 of 4,758, newest first